Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

2.5K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.5K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.6K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.6K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.2K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.2K
Anatomy of the Intestines01:23

Anatomy of the Intestines

87.9K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
87.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Off-label prescribing in ophthalmology: a retrospective analysis.

Frontiers in pharmacology·2026
Same author

Symptom profiles at baseline are associated with remission in major depression: a confirmatory analysis of the PANDORA trial.

Journal of psychiatric research·2026
Same author

Effects of New P2X7R Antagonists on Retinal Inflammatory Degenerative Conditions.

Inflammation·2026
Same author

Tardive dyskinesia and cognitive performances in late-life depression: a sex-stratified analysis.

Psychiatry research·2026
Same author

Global & regional health technology assessment·2026
Same author

Dose-dependent pharmacological mechanisms within the Neuroscience-based Nomenclature: a new concept to facilitate neuroscience-based prescribing.

The lancet. Psychiatry·2026

Related Experiment Video

Updated: Feb 13, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Anorectal mucosal melanoma.

Giulia Malaguarnera1,2, Roberto Madeddu3, Vito Emanuele Catania4

  • 1Research Center "The Great Senescence", University of Catania, Catania, Italy.

Oncotarget
|March 2, 2018
PubMed
Summary
This summary is machine-generated.

Anorectal melanoma, a rare and aggressive cancer, presents diagnostic and therapeutic challenges. Research is exploring molecular targets for advanced treatments, including immunotherapy.

Keywords:
anorectal melanomaanorectal tumoursmalignant melanomamucosal melanomatreatment

More Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K

Related Experiment Videos

Last Updated: Feb 13, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K

Area of Science:

  • Oncology
  • Gastroenterology
  • Dermatology

Background:

  • Anorectal melanoma is a rare, aggressive malignancy of melanocytes.
  • Pre-operative diagnosis is challenging due to non-specific symptoms like anal bleeding or pain.
  • Optimal therapeutic strategies remain unclear, despite a poor prognosis.

Purpose of the Study:

  • To review the diagnostic and therapeutic challenges of anorectal melanoma.
  • To discuss current treatment modalities and emerging strategies for advanced disease.

Main Methods:

  • Literature review of anorectal melanoma diagnosis and treatment.
  • Analysis of surgical options, including wide local excision, endoscopic mucosal resection (EMR), and abdomino-perineal resection.
  • Discussion of the role of radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

Main Results:

  • Anorectal melanoma diagnosis is difficult due to non-specific initial symptoms.
  • Surgical resection is the primary treatment, but optimal procedures are debated.
  • The efficacy of radiation and chemotherapy is uncertain; advanced treatments are evolving.

Conclusions:

  • Anorectal melanoma requires a multidisciplinary approach.
  • Further research into molecular determinants is crucial for effective targeted therapies and immunotherapy.
  • Optimizing treatment strategies is essential for improving patient outcomes.